Title:
METHOD AND AGENT FOR TREATING MEF2D-FUSIBLE ACUTE LYMPHOBLASTIC LEUKEMIA
Document Type and Number:
Japanese Patent JP2021127292
Kind Code:
A
Abstract:
To provide a method and an agent for treating MEF2D-fusible acute lymphoblastic leukemia.SOLUTION: The present disclosure provides a treatment agent containing an SREBF1 activity inhibitor.SELECTED DRAWING: None
Inventors:
TSUZUKI SHINOBU
Application Number:
JP2020020730A
Publication Date:
September 02, 2021
Filing Date:
February 10, 2020
Export Citation:
Assignee:
AICHI MEDICAL UNIV
International Classes:
A61K45/00; A61K31/19; A61K31/202; A61K31/232; A61K31/4439; A61K31/56; A61K31/7105; A61K31/713; A61K35/60; A61K48/00; A61P35/02; A61P43/00
Attorney, Agent or Firm:
Isshiki International Patent Service Corporation